Clinical workflow for MR-only simulation and planning in prostate

被引:82
|
作者
Tyagi, Neelam [1 ]
Fontenla, Sandra [1 ]
Zelefsky, Michael [2 ]
Chong-Ton, Marcia [2 ]
Ostergren, Kyle [3 ]
Shah, Niral [1 ]
Warner, Lizette [4 ]
Kadbi, Mo [4 ]
Mechalakos, Jim [1 ]
Hunt, Margie [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10065 USA
[3] MIM Software Inc, Cleveland, OH 44122 USA
[4] Philips Healthcare, 595 Milner Rd, Cleveland, OH 44143 USA
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
Synthetic CT; MRCAT; Clinical workflow; Prostate cancer; RADIATION-THERAPY; CANCER; CT; MULTIOBSERVER; RADIOTHERAPY; ACCURACY; STANDARD; IMAGES; SPACER;
D O I
10.1186/s13014-017-0854-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To describe the details and experience of implementing a MR-only workflow in the clinic for simulation and planning of prostate cancer patients. Methods: Forty-eight prostate cancer patients from June 2016 -Dec 2016 receiving external beam radiotherapy were scheduled to undergo MR-only simulation. MR images were acquired for contouring (T2w axial, coronal, sagittal), synthetic-CT generation (3D FFE-based) and fiducial identification (3D bFFE-based). The total acquisition time was 25 min. Syn-CT was generated at the console using commercial software called MRCAT. As part of acceptance testing of the MRCAT package, external laser positioning system QA (< 2 mm) and geometric fidelity QA (< 2 mm within 50 cm LR and 30 cm AP) were performed and baseline values were set. Our current combined CT + MR simulation process was modified to accommodate a MRCAT-based MR-only simulation workflow. An automated step-by-step process using a MIMTM workflow was created for contouring on the MR images. Patient setup for treatment was achieved by matching the MRCAT DRRs with the orthogonal KV radiographs based on either fiducial ROIs or bones. 3-D CBCTs were acquired and compared with the MR/syn-CT to assess the rectum and bladder filling compared to simulation conditions. Results: Forty-two patients successfully underwent MR-only simulation and met all of our institutional dosimetric objectives that were developed based on a CT + MR-based workflow. The remaining six patients either had a hip prosthesis or their large body size fell outside of the geometric fidelity QA criteria and thus they were not candidates for MR-only simulation. A total time saving of similar to 15 min was achieved with MR-based simulation as compared to CT + MR-based simulation. An automated and organized MIM workflow made contouring on MR much easier, quicker and more accurate compared with combined CT + MR images because the temporal variations in normal structure was minimal. 2D and 3D treatment setup localization based on bones/fiducials using a MRCAT reference image was successfully achieved for all cases. Conclusions: MR-only simulation and planning with equivalent or superior target delineation, planning and treatment setup localization accuracy is feasible in a clinical setting. Future work will focus on implementing a robust 3D isotropic acquisition for contouring.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Clinical workflow for MR-only simulation and planning in prostate
    Neelam Tyagi
    Sandra Fontenla
    Michael Zelefsky
    Marcia Chong-Ton
    Kyle Ostergren
    Niral Shah
    Lizette Warner
    Mo Kadbi
    Jim Mechalakos
    Margie Hunt
    Radiation Oncology, 12
  • [2] Clinical experience and workflow challenges with magnetic resonance-only radiation therapy simulation and planning for prostate cancer
    Tyagi, Neelam
    Zelefsky, Michael J.
    Wibmer, Andreas
    Zakian, Kristen
    Burleson, Sarah
    Happersett, Laura
    Halkola, Aleksi
    Kadbi, Mo
    Hunt, Margie
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2020, 16 : 43 - 49
  • [3] Validation of the dosimetric and geometric accuracy of MR-only treatment planning solution for prostate cancer radiotherapy
    Posiewnik, Michal
    Piotrowski, Tomasz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2021, 25 (04): : 241 - 245
  • [4] Validation of the dosimetric accuracy of MR-only treatment planning solution for prostate cancer
    Tejedor, Natalia
    Jornet, Nuria
    Gallego, Pedro
    Sancho, Gemma
    Soto-Cambres, Ana Maria
    Mera, Arantxa
    Perez-Alija, Jaime
    Anson, Cristina
    Vivancos, Helena
    Ruiz, Agustin
    Barcelo, Marta
    Leo, Fatima
    Dominguez, Alejandro
    Riu, Victor
    Carrasco, Pablo
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S3951 - S3954
  • [5] Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
    Goudschaal, Karin
    Beeksma, F.
    Boon, M.
    Bijveld, M.
    Visser, J.
    Hinnen, K.
    van Kesteren, Z.
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [6] FMEA of MR-Only Treatment Planning in the Pelvis
    Kim, Joshua
    Miller, Brett
    Siddiqui, M. Salim
    Movsas, Benjamin
    Glide-Hurst, Carri
    ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (01) : 168 - 176
  • [7] Geometric and dosimetric impact of anatomical changes for MR-only radiation therapy for the prostate
    Nejad-Davarani, Siamak P.
    Sevak, Parag
    Moncion, Michael
    Garbarino, Kimberly
    Weiss, Steffen
    Kim, Joshua
    Schultz, Lonni
    Elshaikh, Mohamed A.
    Renisch, Steffen
    Glide-Hurst, Carri
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2019, 20 (04): : 10 - 17
  • [8] Comparison of four synthetic CT generators for brain and prostate MR-only workflow in radiotherapy
    Autret, Damien
    Guillerminet, Camille
    Roussel, Alban
    Cossec-Kerloc'h, Erwan
    Dufreneix, Stephane
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [9] Comparison of four synthetic CT generators for brain and prostate MR-only workflow in radiotherapy
    Damien Autret
    Camille Guillerminet
    Alban Roussel
    Erwan Cossec-Kerloc’h
    Stéphane Dufreneix
    Radiation Oncology, 18 (1)
  • [10] Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
    Karin Goudschaal
    F. Beeksma
    M. Boon
    M. Bijveld
    J. Visser
    K. Hinnen
    Z. van Kesteren
    Radiation Oncology, 16